glp-1 and ulcerative colitis Benefits For People With Obesity SAFETY AND CLINICAL EFFECTIVENESS OF
Description
Eligible participants had an HbA1c level between 7.0% and 10.5%, a fasting plasma glucose (FPG) 7.0 mmol/L and 13.9 mmol/L at randomization, and a body mass index (BMI) between 20.0 kg/m 2 and 35.0 kg/m 2
People who want to avoid injections
GLP-1s have reshaped weight management and type 2 diabetes treatment, offering clinically proven blood sugar control and weight loss
Patients taking GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) often wonder how much fiber per day on GLP-1 therapy is appropriate
Darwish, A
